Tumor Image-Guided Platform R&D Deemed Critical To Therapy Effectiveness
This article was originally published in The Gray Sheet
Executive Summary
"Real-time" cancer imaging modalities will allow more targeted drug and biologic treatment delivery to tumor sites, cancer researchers agreed at the Radiological Society of North America annual meeting Nov. 29
You may also be interested in...
Fusion Imaging Software May Circumvent Need For Dual-Modality Devices
Future applications of fusion imaging will permit viewing of coronary artery disease, end-organ perfusion abnormality and wall-thickening abnormality in a single picture, University of New Mexico radiologist Michael Hartshorne, MD, said Nov. 29
Fusion Imaging Software May Circumvent Need For Dual-Modality Devices
Future applications of fusion imaging will permit viewing of coronary artery disease, end-organ perfusion abnormality and wall-thickening abnormality in a single picture, University of New Mexico radiologist Michael Hartshorne, MD, said Nov. 29
InSightec ExAblate 2000 Approved For Uterine Fibroids; 3-Year Study Required
FDA approval conditions for InSightec's ExAblate 2000 uterine fibroid ultrasound treatment respond to advisory panel concerns about short-term safety and efficacy data in the original PMA submission